EP0328685B1 — Powdery medicine applicator device
Assigned to Teijin Ltd · Expires 1992-05-13 · 34y expired
What this patent protects
A powdery medicine applicator device comprising a medicine-holding portion (1) having a powdery medicine (7) sealed therein, which has an opening formed at the head thereof to spray or inhale the powdery medicine (7), an air-introducing means (3, 10), and, if desired, a desiccant…
USPTO Abstract
A powdery medicine applicator device comprising a medicine-holding portion (1) having a powdery medicine (7) sealed therein, which has an opening formed at the head thereof to spray or inhale the powdery medicine (7), an air-introducing means (3, 10), and, if desired, a desiccantholding portion (9). The end of the applicator may be opened either by breaking off a knob (5) formed thereon or by perforation using a cap having a projection (6). The powdery medicine (7) is separated from the air-introducing means (3, 10) by an air-permeable partition wall (2).
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.